| 1 |
2023 |
Glòria Salort, María Álvaro-Bartolomé, Jesús A. García-Sevilla. Cannabinoid CB2 receptor ligands disrupt the sequential regulation of p-MEK1/2 to p-ERK1/2 in mouse brain cortex, Exploration of Neuroprotective Therapy. 2023; 3: 258.
https://doi.org/10.37349/ent.2023.00050 |
| 2 |
2024 |
Joan Serrano-Marín, Rita Valenzuela, Cristina Delgado, Aloia Quijano, Gemma Navarro, José Luis Labandeira –García, Rafael Franco. Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia, Mitochondrion. 2024; 78: 101934101934.
https://doi.org/10.1016/j.mito.2024.101934 |
| 3 |
2024 |
David Bernal-Casas, Joan Serrano-Marín, Juan Sánchez-Navés, Josep M. Oller, Rafael Franco. Advancing Personalized Medicine by Analytical Means: Selection of Three Metabolites That Allows Discrimination between Glaucoma, Diabetes, and Controls, Metabolites. 2024; 14: 149.
https://doi.org/10.3390/metabo14030149 |
| 4 |
2023 |
Rafael Franco, Joan Serrano-Marín, Gemma Navarro, Rafael Rivas-Santisteban. The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons, Antioxidants. 2023; 12: 1869.
https://doi.org/10.3390/antiox12101869 |
| 5 |
2024 |
Rafael Franco, Vitactions: vitamins for the brain, Exploration of Neuroprotective Therapy. 2024; 300.
https://doi.org/10.37349/ent.2024.00084 |
